Taussig Cancer Institute appoints director of genitourinary medical oncology
Click Here to Manage Email Alerts
Shilpa Gupta, MD, has been appointed director of genitourinary medical oncology at Taussig Cancer Institute and co-leader of the genitourinary oncology program at Cleveland Clinic.
Gupta joined Cleveland Clinic’s genitourinary cancer program in 2019.
Her research interests include novel drug development and understanding biomarkers of response and treatment resistance in bladder cancer. She has led several investigator-initiated trials in genitourinary cancer.
“Dr. Gupta is an influential leader in genitourinary oncology and bladder cancer research that focuses on improving clinical outcomes and quality of life,” Jame Abraham, MD, interim chair of Cleveland Clinic Taussig Cancer Institute, told Healio. “Her new appointments are well-deserved, and we are confident she will continue to be instrumental to the growth and success of Cleveland Clinic Cancer Center.”
Gupta previously served on the faculty in the division of hematology, oncology and transplantation at University of Minnesota, where she also led the interdisciplinary solid tumor phase 1 program.
Collapse
Press Release
Read more about
Click Here to Manage Email Alerts